Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis

Published:2008 Issue:48 Volume:14 Page:7361
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Ford Alexander C,Malfertheiner Peter,Giguère Monique,Santana José,Khan Mostafizur,Moayyedi Paul

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference52 articles.

1. Tillman LA, Drake FM, Dixon JS, Wood JR. Review article: safety of bismuth in the treatment of gastrointestinal diseases. Aliment Pharmacol Ther 1996;10:459-467.

2. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;321:1273-1275.

3. Wolle K, Malfertheiner P. Treatment of Helicobacter pylori. Best Pract Res Clin Gastroenterol 2007;21:315-324.

4. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;1:1311-1315.

5. McNulty CA, Gearty JC, Crump B, Davis M, Donovan IA, Melikian V, Lister DM, Wise R. Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Br Med J (Clin Res Ed) 1986;293:645-649.

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Standard Triple Therapy for Helicobacter pylori Eradication in Latin America;Journal of Clinical Gastroenterology;2024-09-02

2. Allosteric Regulation and Inhibition of Coronavirus 3CLpro Revealed by HDX‐MS;ChemBioChem;2024-06-21

3. Bismuth add-on improves the efficacy of 2-week tegoprazan-based triple therapy for first-line Helicobacter pylori eradication: a real-world evidence study;Expert Review of Anti-infective Therapy;2024-03-13

4. Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects;Drugs in R&D;2024-02-12

5. Ilaprazole-amoxicillin dual therapy at high dose as a first-line treatment for helicobacter pylori infection in Hainan: a single-center, open-label, noninferiority, randomized controlled trial;BMC Gastroenterology;2023-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3